LRPAP1 antibody treatment also significantly protected cells from cytopathic effects (CPE) caused by virus infection (Supplementary Fig. S2a), indicating the extracellular LRPAP1 induced by HCoV-OC43 promoted viral infection. This evidence concerns the gene LRPAP1 and viral infectious disease.